-5%
Linajen is used to improve blood sugar control in adults with type 2 diabetes mellitus.
It may be prescribed:
- As monotherapy for patients who cannot use metformin due to intolerance or contraindications such as renal impairment, and whose blood glucose is not adequately controlled with diet and exercise alone.
As combination therapy:
- With metformin, when lifestyle measures plus metformin are insufficient
- With metformin and a sulfonylure,a when triple therapy is required to achieve glycaemic targets
Type 2 diabetes is a common condition where the body does not produce enough insulin or the insulin produced does not work effectively. This leads to increased blood glucose levels. Symptoms include frequent urination, excessive thirst, and increased hunger.
If not properly managed, diabetes can cause long-term complications such as nerve damage, kidney problems, eye issues, foot complications, and an increased risk of heart disease.
Linajen 5 contains Linagliptin, which belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors used Linajen 5 is prescribed for the condition of type 2 diabetes when diet and exercise alone cannot control their blood sugar levels. It works by blocking the action of DPP-4 helps produce more insulin only when required, and reduces the blood sugar level when not needed‚ Linajen 5 should not be used in patients with type 1 diabetes and for the treatment of diabetic ketoacidosis. Use with caution in patients with known hypersensitivity to Linagliptin or any excipients